Clinics in Dermatology
Volume 27, Issue 4 , Pages 339-345, July 2009

The ethics of consulting with pharmaceutical companies

  • Andrew Miner, BS

      Affiliations

    • The University of Texas Southwestern, Dallas, TX, USA
    • ,
  • Alan Menter, MD

      Affiliations

    • Division of Dermatology, Baylor University Medical Center, 3900 Junius Street, Suite 145, Dallas, TX 75246, USA
    • Corresponding Author InformationCorresponding author.

Abstract 

Acting as a speaker or consultant to the pharmaceutical industry, while adding to a physician's recognition and income, serves a vital role in graduate and postgraduate medical education. Such activities work, especially when one becomes involved with several different companies or organizations, can expose the speaker and researcher to a number of potential ethical conflicts. These include publication and prescribing bias. These also lead to the real or apparent conflict of interest when the consultant receives unearned, unjustified, or excessive compensation and gifts.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0738-081X(09)00024-8

doi:10.1016/j.clindermatol.2009.02.004

Clinics in Dermatology
Volume 27, Issue 4 , Pages 339-345, July 2009

Article Tools